457 related articles for article (PubMed ID: 25663078)
21. Significance of data mining in routine signal detection: Analysis based on the safety signals identified by the FDA.
Fukazawa C; Hinomura Y; Kaneko M; Narukawa M
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1402-1408. PubMed ID: 30324671
[TBL] [Abstract][Full Text] [Related]
22. Application and optimisation of the Comparison on Extreme Laboratory Tests (CERT) algorithm for detection of adverse drug reactions: Transferability across national boundaries.
Tham MY; Ye Q; Ang PS; Fan LY; Yoon D; Park RW; Ling ZJ; Yip JW; Tai BC; Evans SJ; Sung C
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):87-94. PubMed ID: 29108136
[TBL] [Abstract][Full Text] [Related]
23. Development of an electronic trigger tool at a children's hospital within an academic medical center.
Fortenberry M; Odinet J; Shah P; McKinzie C; Murphy K; Faircloth CB; Falato C; Pappas A
Am J Health Syst Pharm; 2019 Nov; 76(Supplement_4):S107-S113. PubMed ID: 31724037
[TBL] [Abstract][Full Text] [Related]
24. Automatic detection of adverse events to predict drug label changes using text and data mining techniques.
Gurulingappa H; Toldo L; Rajput AM; Kors JA; Taweel A; Tayrouz Y
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1189-94. PubMed ID: 23935003
[TBL] [Abstract][Full Text] [Related]
25. A reference set of clinically relevant adverse drug-drug interactions.
Kontsioti E; Maskell S; Dutta B; Pirmohamed M
Sci Data; 2022 Mar; 9(1):72. PubMed ID: 35246559
[TBL] [Abstract][Full Text] [Related]
26. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
Trifirò G; Pariente A; Coloma PM; Kors JA; Polimeni G; Miremont-Salamé G; Catania MA; Salvo F; David A; Moore N; Caputi AP; Sturkenboom M; Molokhia M; Hippisley-Cox J; Acedo CD; van der Lei J; Fourrier-Reglat A;
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1176-84. PubMed ID: 19757412
[TBL] [Abstract][Full Text] [Related]
27. Trivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA System Organ Classes Using VAERS Data.
Tao C; Du J; Cai Y; Chen Y
Stud Health Technol Inform; 2015; 216():1076. PubMed ID: 26262375
[TBL] [Abstract][Full Text] [Related]
28. A Comparison Study of Algorithms to Detect Drug-Adverse Event Associations: Frequentist, Bayesian, and Machine-Learning Approaches.
Pham M; Cheng F; Ramachandran K
Drug Saf; 2019 Jun; 42(6):743-750. PubMed ID: 30762164
[TBL] [Abstract][Full Text] [Related]
29. Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database.
Hunt CM; Yuen NA; Stirnadel-Farrant HA; Suzuki A
Regul Toxicol Pharmacol; 2014 Nov; 70(2):519-26. PubMed ID: 25236535
[TBL] [Abstract][Full Text] [Related]
30. Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.
Martin D; Menschik D; Bryant-Genevier M; Ball R
Drug Saf; 2013 Jul; 36(7):547-56. PubMed ID: 23657824
[TBL] [Abstract][Full Text] [Related]
31. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register.
Wallerstedt SM; Brunlöf G; Sundström A
Drug Saf; 2011 Aug; 34(8):669-82. PubMed ID: 21751827
[TBL] [Abstract][Full Text] [Related]
32. Data mining spontaneous adverse drug event reports for safety signals in Singapore - a comparison of three different disproportionality measures.
Ang PS; Chen Z; Chan CL; Tai BC
Expert Opin Drug Saf; 2016 May; 15(5):583-90. PubMed ID: 26996192
[TBL] [Abstract][Full Text] [Related]
33. Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database.
Park K; Soukavong M; Kim J; Kwon KE; Jin XM; Lee J; Yang BR; Park BJ
Yonsei Med J; 2017 May; 58(3):564-569. PubMed ID: 28332362
[TBL] [Abstract][Full Text] [Related]
34. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.
Szarfman A; Machado SG; O'Neill RT
Drug Saf; 2002; 25(6):381-92. PubMed ID: 12071774
[TBL] [Abstract][Full Text] [Related]
35. Prospective data mining of six products in the US FDA Adverse Event Reporting System: disposition of events identified and impact on product safety profiles.
Bailey S; Singh A; Azadian R; Huber P; Blum M
Drug Saf; 2010 Feb; 33(2):139-46. PubMed ID: 20082540
[TBL] [Abstract][Full Text] [Related]
36. A pipeline to extract drug-adverse event pairs from multiple data sources.
Yeleswarapu S; Rao A; Joseph T; Saipradeep VG; Srinivasan R
BMC Med Inform Decis Mak; 2014 Feb; 14():13. PubMed ID: 24559132
[TBL] [Abstract][Full Text] [Related]
37. Illustration of the weibull shape parameter signal detection tool using electronic healthcare record data.
Sauzet O; Carvajal A; Escudero A; Molokhia M; Cornelius VR
Drug Saf; 2013 Oct; 36(10):995-1006. PubMed ID: 23673816
[TBL] [Abstract][Full Text] [Related]
38. Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.
Iqbal S; Shi J; Seib K; Lewis P; Moro PL; Woo EJ; Shimabukuro T; Orenstein WA
Lancet Infect Dis; 2015 Oct; 15(10):1175-1182. PubMed ID: 26289956
[TBL] [Abstract][Full Text] [Related]
39. The class imbalance problem detecting adverse drug reactions in electronic health records.
Santiso S; Casillas A; Pérez A
Health Informatics J; 2019 Dec; 25(4):1768-1778. PubMed ID: 30230408
[TBL] [Abstract][Full Text] [Related]
40. JADE: a tool for medical researchers to explore adverse drug events using health claims data.
Edlinger D; Sauter SK; Rinner C; Neuhofer LM; Wolzt M; Grossmann W; Endel G; Gall W
Appl Clin Inform; 2014; 5(3):621-9. PubMed ID: 25298803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
